Curated News:

NEJM

Add to Favorites Subscribe Share
fbshare-NEJM

Showing results

110 of 338
Embargo will expire:
18-Sep-2019 5:00 PM EDT
Released to reporters:
16-Sep-2019 1:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
18-Sep-2019 5:00 PM EDT
Released to reporters:
13-Sep-2019 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Lowy Medical Research Institute Scientists Find Cause of Debilitating Eye Disease
  • Embargo expired:
    11-Sep-2019 5:00 PM EDT

Article ID: 718598

Lowy Medical Research Institute Scientists Find Cause of Debilitating Eye Disease

Lowy Medical Research Institute

Scientists at the Lowy Medical Research Institute (LMRI) have discovered one cause of a progressive, debilitating eye disease called macular telangiectasia type 2 (MacTel). The work, using genetic, clinical and biochemical studies has implications for other retinal eye diseases, as well as peripheral neuropathies.

Released:
9-Sep-2019 1:00 PM EDT
Newswise: John A. Moran Eye Center Researcher, Patients, Play Key Role in Genetic Discovery Linked to Rare Eye Disease
  • Embargo expired:
    11-Sep-2019 5:00 PM EDT

Article ID: 718807

John A. Moran Eye Center Researcher, Patients, Play Key Role in Genetic Discovery Linked to Rare Eye Disease

University of Utah Health

Paul S. Bernstein, MD, PhD, spent more than a decade working with families at the John A. Moran Eye Center at the University of Utah on the hunt for the first gene known to cause a rare retinal disease known as MacTel.

Released:
11-Sep-2019 10:00 AM EDT

Research Results

Channels:

All Journal News, Genetics, Vision, NEJM

Languages:

English

Newswise: Unmarried Patients Less Likely to Survive Cancer as Bias Drives Treatments

Article ID: 718697

Unmarried Patients Less Likely to Survive Cancer as Bias Drives Treatments

University of Delaware

Unmarried patients with cancer are less likely to get potentially life-saving surgery or radiotherapy than their married counterparts, raising the concern that medical providers may be relying on stereotypes that discount sources of social support other than a current spouse. That's the conclusion reached by the University of Delaware's Joan DelFattore, a professor emerita who combined her personal experience as an unmarried patient with her skills as a researcher to publish a peer-reviewed article in the latest issue of The New England Journal of Medicine.

Released:
9-Sep-2019 4:05 PM EDT
Newswise: Preventative artery repair provides major benefit after serious heart attack
  • Embargo expired:
    1-Sep-2019 8:30 AM EDT

Article ID: 718210

Preventative artery repair provides major benefit after serious heart attack

McMaster University

The new study, a collaboration of 130 hospitals in 31 countries, has shown that opening all the blockages is better than treating only the one blockage causing the heart attack. This led to a 26 per cent reduction in the patient’s risk of dying or having a recurrent heart attack.

Released:
28-Aug-2019 4:55 PM EDT
  • Embargo expired:
    21-Aug-2019 5:00 PM EDT

Article ID: 717580

Unprecedented Therapy Found Effective for Blood Cancer Patients With No Treatment Options

Mount Sinai Health System

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

Released:
16-Aug-2019 11:00 AM EDT
Signature-Vertical.png
  • Embargo expired:
    14-Aug-2019 5:00 PM EDT

Article ID: 717251

Surgeons report success in reducing opioid prescribing without increasing patients’ pain

Michigan Medicine - University of Michigan

A new study shows how one state’s surgeons reduced the number of opioids they prescribed to thousands of patients -- without causing patients to feel more pain or less satisfied with their surgical experience.

Released:
9-Aug-2019 10:30 AM EDT
HSC-1489-NewsHeader-1200w.png

Article ID: 717142

Promising Clinical Trial Results for Drug for Rare Disease in Which Patients Can’t Eat Fat

University of California San Diego Health

In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.

Released:
8-Aug-2019 4:25 AM EDT
UH_Cleveland_RGB.jpg
  • Embargo expired:
    31-Jul-2019 5:05 PM EDT

Article ID: 716559

Physician Leaders Call for Action to Create a New Generation of Physician-Scientists

University Hospitals Cleveland Medical Center

In a perspective article in the New England Journal of Medicine, a group of prominent physician-scientist leaders proposes a plan for increasing the number of physicians who conduct research looking for tomorrow’s breakthroughs and cures. They write, “Revitalizing the physician-scientist pipeline is of critical importance to overcoming current and future health challenges.”

Released:
29-Jul-2019 4:00 PM EDT

Showing results

110 of 338

Chat now!